Decheng Capital »

Newamsterdam Pharma Co Nv shares owned by Decheng Capital

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Decheng Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.8M 590k 16.60
2024-06-30 $7.7M 400k 19.21

More positions owned by Decheng Capital

Cg Oncology (CGON)
Nuvation Bio (NUVB)
Phathom Pharmaceuticals (PHAT)
Arcus Biosciences Incorporated (RCUS)
Krystal Biotech (KRYS)
Illumina (ILMN)
Zentalis Pharmaceuticals (ZNTL)
BeyondSpring SHS (BYSI)
Newamsterdam Pharma Co Nv (NAMS)
Merus N V (MRUS)
Helix Acquisition Corp
Crinetics Pharmaceuticals In (CRNX)
Legend Biotech Corp- Adr (LEGN)
Cytokinetics (CYTK)
Aura Biosciences (AURA)

View all positions for Decheng Capital

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
BVF
Woodline Partners
Jennison Associates
Henderson Group
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management

View all funds holding Newamsterdam Pharma Co Nv